Saple, D. G., Save, S., Kumar, D., & Sood, S. (2022). An open label, single arm, pilot study to evaluate the safety, tolerability, and efficacy of daily fluconazole 150 mg in subjects suffering from Tinea cruris and Tinea corporis [version 2; peer review: 1 approved with reservations, 1 not approved]. F1000 research, 11, 1446. https://doi.org/10.12688/f1000research.127138.2
Citácia podle Chicago (17th ed.)Saple, Dattatray Gopal, Sushrut Save, Devesh Kumar, a Suneet Sood. "An Open Label, Single Arm, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of Daily Fluconazole 150 Mg in Subjects Suffering from Tinea Cruris and Tinea Corporis [version 2; Peer Review: 1 Approved with Reservations, 1 Not Approved]." F1000 Research 11 (2022): 1446. https://doi.org/10.12688/f1000research.127138.2.
Citácia podľa MLA (8th ed.)Saple, Dattatray Gopal, et al. "An Open Label, Single Arm, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of Daily Fluconazole 150 Mg in Subjects Suffering from Tinea Cruris and Tinea Corporis [version 2; Peer Review: 1 Approved with Reservations, 1 Not Approved]." F1000 Research, vol. 11, 2022, p. 1446, https://doi.org/10.12688/f1000research.127138.2.